Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Construction in Progress (2019 - 2022)

Eton Pharmaceuticals (ETON) has disclosed Construction in Progress for 3 consecutive years, with $12000.0 as the latest value for Q4 2022.

  • Quarterly Construction in Progress changed N/A to $12000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $12000.0 through Dec 2022, changed N/A year-over-year, with the annual reading at $12000.0 for FY2022, N/A changed from the prior year.
  • Construction in Progress hit $12000.0 in Q4 2022 for Eton Pharmaceuticals, roughly flat from $12000.0 in the prior quarter.
  • In the past five years, Construction in Progress ranged from a high of $873000.0 in Q1 2019 to a low of $1000.0 in Q3 2020.
  • Historically, Construction in Progress has averaged $130571.4 across 3 years, with a median of $9000.0 in 2019.
  • Biggest YoY gain for Construction in Progress was 66.67% in 2020; the steepest drop was 99.54% in 2020.
  • Year by year, Construction in Progress stood at $9000.0 in 2019, then tumbled by 88.89% to $1000.0 in 2020, then soared by 1100.0% to $12000.0 in 2022.
  • Business Quant data shows Construction in Progress for ETON at $12000.0 in Q4 2022, $12000.0 in Q1 2022, and $1000.0 in Q3 2020.